Am J Geriatr Psychiatry
Alzheimer DiseaseDouble-Blind MethodLithium
Deborah Deliyannides
NPI1396874921
- Part D claims, 2024
- 315
- Publications
- 14
- Clinical trials
- 1
- Industry payments
- $50
- State licenses
- 2
- Practice address
- 30 E 76th St, New York, NY 10021
- Practice phone
- Call (212) 794-3550
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
New York Headache Center
New York, New York
Find Deborah Deliyannides' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Deborah Deliyannides is a psychiatrist in New York, New York
Deborah Deliyannides practices at New York Headache Center in New York, New York.
Deborah Deliyannides' NPI, 1396874921, was assigned on March 2, 2007. Deborah Deliyannides graduated from Sidney Kimmel Medical College in 1985. Deborah Deliyannides' New York license number on file is 168059.
NPI and contact details
- NPI
- 1396874921NPI Registry (opens in a new tab)
- NPI enumeration date
- March 2, 2007
- NPI status
- Active
- Practice phone
- (212) 794-3550
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Medical school graduation
- 1985
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Deborah Deliyannides practices at New York Headache Center in New York, New York
Deborah Deliyannides' primary practice is New York Headache Center, at 30 E 76th St, New York, NY 10021 in New York County. The practice phone is (212) 794-3550.
- New York Headache Center30 E 76th St, New York, NY 10021 · New York CountyPhone(212) 794-3550
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Deborah Deliyannides is affiliated with 1 site of care
Deborah Deliyannides' primary practice is New York Headache Center in New York, New York.
New York Headache CenterPrimary
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Deborah Deliyannides' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Deborah Deliyannides practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| New York Headache Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Deborah Deliyannides practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Deborah Deliyannides is one of 4,448 psychiatrists in New York
Psychiatry is Deborah Deliyannides' primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Deborah Deliyannides is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Deborah Deliyannides' licenses on file in 2 states: New York and Connecticut.
Specialties and state licenses
- Psychiatry, New YorkPrimary
- Connecticut license
Psychiatrists near Deborah Deliyannides
Counts of psychiatrists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Deborah Deliyannides' patients have a median age of 34
Across all payers, Dmand AI patient panel data puts Deborah Deliyannides' median patient age at 34, with 63% women.
Deborah Deliyannides' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 34
Patient panel by sex, all payers
- Women63%
- Men38%
Source: Dmand AI Patient Panel Data
Deborah Deliyannides wrote 315 Medicare Part D claims in 2024
In 2024, Deborah Deliyannides wrote 315 Medicare Part D claims for 38 patients. 96% of them were for generic drugs. CMS names the drug for 222 of them, across 11 drugs with 11 or more claims each, at $4,992 in total drug cost. In 2023, CMS named 235 claims across 12 drugs.
Part D claims, 2024315
Drugs named by CMS11
Total drug cost$4,992
Part D patients38
Deborah Deliyannides' Part D claims by kind of drug, 2024
- Generic301 claims96%
- Brand-name14 claims4%
Deborah Deliyannides' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Deborah Deliyannides' Part D claims, 2024
- Antipsychotics, patients 65 and over15%48 of 315 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2352024: 2226%
Drugs named by CMS: 11 in 2024, 12 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Find psychiatrists like Deborah Deliyannides by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Deborah Deliyannides has 14 publications on record
Dmand AI links 14 papers to Deborah Deliyannides, published from 2010 to 2021. The most frequent topics are Antidepressive Agents, Psychiatric Status Rating Scales and Double-Blind Method. Deborah Deliyannides has published most often in J Clin Psychiatry. Deborah Deliyannides' most frequent co-authors are Patrick J. McGrath, MD, Jonathan W. Stewart, MD and Davangere P. Devanand.
Papers14
Years published2010 to 2021
Deborah Deliyannides' papers by year, 2010 to 2021
Topics Deborah Deliyannides writes about most
- Antidepressive Agents
- Psychiatric Status Rating Scales
- Double-Blind Method
- Depressive Disorder
- Depressive Disorder, Major
- Alzheimer Disease
- Drug Therapy, Combination
- Placebos
Deborah Deliyannides' most frequent co-authors
- Patrick J. McGrath, MD4 shared papers
- Jonathan W. Stewart, MD4 shared papers
- Davangere P. Devanand3 shared papers
Recent publications by Deborah Deliyannides
Alzheimer DiseaseAmyloid beta-PeptidesAntiviral Agents
J Affect Disord
Antidepressive AgentsCentral Nervous System StimulantsDepressive Disorder, Major
J Psychiatr Res
Analysis of VarianceAntidepressive AgentsBupropion
J Clin Psychiatry
Antidepressive AgentsDepressive Disorder, MajorPsychiatric Status Rating Scales
See who Deborah Deliyannides researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Deborah Deliyannides works with, so you can find a warm path to the right psychiatrists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Deborah Deliyannides has worked on 1 clinical trial
Dmand AI links Deborah Deliyannides to 1 clinical trial. Conditions studied include Bipolar and Related Disorders and Bipolar Disorder.
Conditions in Deborah Deliyannides' trials
- Bipolar and Related Disorders
- Bipolar Disorder
Investigators on the most trials with Deborah Deliyannides
Recent clinical trials with Deborah Deliyannides
Bipolar and Related DisordersBipolar DisorderTranylcypromine
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Deborah Deliyannides received $50 in industry payments in 2016
CMS Open Payments shows 2 general payments to Deborah Deliyannides from 2 drug and device companies in 2016. Education make up the largest share, 75% of the total. Shire North American Group Inc paid the most, $38.
General payments to Deborah Deliyannides by kind, 2016 to 2016
$50in total
- Education$3875%
- Food and beverage$1225%
Companies that paid Deborah Deliyannides the most, 2016 to 2016
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Deborah Deliyannides graduated from Sidney Kimmel Medical College
Deborah Deliyannides graduated from Sidney Kimmel Medical College in 1985.
- Medical school
- Board certified in psychiatry
Source: Dmand AI Professional Profile Data
Sources for Deborah Deliyannides's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Deborah Deliyannides
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Deborah Deliyannides' NPI number?
Deborah Deliyannides' NPI number is 1396874921. It was assigned on March 2, 2007, and it is active in the NPI Registry.
What does Deborah Deliyannides specialize in?
Deborah Deliyannides is a psychiatrist in New York, New York. The primary specialty in the NPI Registry is Psychiatry Physician (taxonomy code 2084P0800X).
Where does Deborah Deliyannides practice?
Deborah Deliyannides practices at 30 E 76th St, New York, NY 10021. Deborah Deliyannides' primary practice is New York Headache Center in New York, New York.
What is Deborah Deliyannides' office phone number?
The practice phone on file for Deborah Deliyannides is (212) 794-3550.
What is Deborah Deliyannides' medical license number?
Deborah Deliyannides' New York license number on file is 168059, one of the licenses on file in 2 states.
Which states has Deborah Deliyannides been licensed in?
Dmand AI has state licenses on file for Deborah Deliyannides in New York (1986 to 2025) and Connecticut (1994 to 2026).
Is Deborah Deliyannides board certified?
Yes. Deborah Deliyannides is board certified in psychiatry by the American Board of Psychiatry and Neurology.
Where did Deborah Deliyannides go to medical school?
Deborah Deliyannides graduated from Sidney Kimmel Medical College in 1985.
What drugs does Deborah Deliyannides prescribe most?
In 2024 Medicare Part D data, Deborah Deliyannides' most prescribed drugs by claims were Duloxetine HCl, Quetiapine Fumarate and Sertraline HCl.
Has Deborah Deliyannides received payments from drug or device companies?
CMS Open Payments shows $50 in general payments to Deborah Deliyannides from 2 companies from 2016 to 2016. The largest total came from Shire North American Group Inc.
Show 3 more questionsShow fewer questions
How long has Deborah Deliyannides been practicing?
Deborah Deliyannides graduated from medical school in 1985, 41 years ago.
Does Deborah Deliyannides do research?
Dmand AI links 14 publications to Deborah Deliyannides, published from 2010 to 2021. Deborah Deliyannides has worked on 1 clinical trial.
Who does Deborah Deliyannides publish with?
Deborah Deliyannides' most frequent co-authors are Patrick J. McGrath, MD (4 shared papers), Jonathan W. Stewart, MD (4 shared papers) and Davangere P. Devanand (3 shared papers).
Selling to psychiatry practices?
See psychiatrists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card